Skip to main content

$500K Verdict Against J&J in Pelvic Mesh Lawsuit

$500K Verdict Against J&J in Pelvic Mesh Lawsuit

$500K Verdict Against J&J in Pelvic Mesh Lawsuit

Introduction

A plaintiff was awarded $500,000 in damages by the Philadelphia jury in the verdict against Johnson & Johnson’s unit Ethicon on June 28, after finding that the design defects in a pelvic mesh implant left the plaintiff suffering from pain.

The plaintiff was implanted with the mesh device in 2007 to assist with a condition known as pelvic organ prolapse. In 2009, the plaintiff’s doctor found that the mesh was eroding the vaginal wall. The first instance of erosion healed on its own. Later in 2015, a severe erosion occurred which resulted in an operation, where most of the implant was removed. The plaintiff claimed that till date, she experiences complications related to mesh implant and removal.

The plaintiff's attorney stated that it is the ninth time in these vaginal mesh cases that Johnson & Johnson has been found to have acted wrongfully. The plaintiff becomes the 11th woman to bring mesh-related claims against Johnson and Johnson subsidiary Ethicon to trial in Philadelphia court. Ethicon stated that they disagree with the jury’s verdict and plans to appeal.

U.S. District Judge Joseph R. Goodwin is presiding overall Ethicon pelvic mesh lawsuits consolidated under multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) in the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!